AlzeCure gets new Alzheimer’s abstract accepted
Therapy is based on ACD856’s indicative disease modifying effects against the condition
Read More
Author: John Pinching
Kite’s Yescarta to receive European marketing authorisation
First treatment in 30 years to improve second-line treatment of DLBCL
Read More
Parliament square set for ME research demonstration
Demonstrators will demand hundreds of millions of pounds ‘missing’ from ME research
Read More
NHS Confederation responds to the appointment of Jeremy Hunt
New Chancellor of the Exchequer left in no doubt regarding challenges ahead
Read More
XBiotech enrols first patient in Natrunix study
Therapy involves patients with colorectal cancer at 20 medical centres
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
